Mark T Jefferson is a notable inventor based in Waterford, CT (US). He has made significant contributions to the field of antibiotic research and development. With a total of 7 patents to his name, Jefferson has been instrumental in advancing medical science.

Latest Patents

Among his latest patents is a process for producing nocardicin A. This innovative method involves a new species of Nocardiopsis, designated Nocardiopsis atra Huang sp. nov., which, when aerobically propagated in an aqueous nutrient medium, produces nocardicin A in good yield. Another significant patent focuses on antibiotics produced by species of Actinoplanes. This patent describes a species of Actinoplanes, designated Actinoplanes deccanensis Parenti, Pagani and Beretta subsp. salmoneus Huang subsp. nov., ATCC 31355, which, when subjected to submerged aerobic fermentation, produces a new antibiotic complex. The methods for the recovery and purification of this antibiotic complex, along with some individual antibiotic components, are also detailed in his work.

Career Highlights

Mark T Jefferson is currently associated with Pfizer Corporation, a leading pharmaceutical company. His work at Pfizer has allowed him to focus on innovative solutions in antibiotic production and purification.

Collaborations

Throughout his career, Jefferson has collaborated with notable colleagues, including Walter D Celmer and Walter P Cullen. These collaborations have further enhanced his research and development efforts in the field of antibiotics.

Conclusion

Mark T Jefferson's contributions to antibiotic research are significant and impactful. His innovative patents and collaborations reflect his dedication to advancing medical science. His work continues to influence the development of new antibiotics, which are crucial for combating bacterial infections.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]